Metraipolis › archive › dc_6585320d423f

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142607
DOI
10.3389/fonc.2025.1688802
License (as archived)
solo-consultazione
Archived
2026-11-09T11:00:58.048Z
SHA-256 of the archived text
f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a
Stable URL of this page
https://metraipolis.com/documento/dc_6585320d423f

How to cite

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607 — Europe PMC (en), https://europepmc.org/article/MED/41142607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6585320d423f (Metraipolis archive dc_6585320d423f, sha256 f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a)
BibTeX
@misc{dc6585320d423f,
  title = {Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142607},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6585320d423f; sha256 f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142607. Agents can read the archived copy with the MCP tool read_document.